Evidence map›Paper›PMID 41178291›Full record

ArticleEpidemiology and infection2025

Risk factors associated with

Ayse Kaya, Fatma Eser, Imran Hasanoglu, Bircan Kayaaslan, Aziz Bozkurt, Ayse Yasemin Tezer Tekce, Bedia Dinc, Fisun Kirca, Hatice Rahmet Guner

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Study Clinical Characteristics and Outcomes ofJournal of clinical medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ayse KayaInfectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Türkiye.ORCID 0000-0002-4759-0066
Fatma EserInfectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Türkiye.
Imran HasanogluInfectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Türkiye.
Bircan KayaaslanInfectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Türkiye.
Aziz BozkurtInfectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara, Türkiye.
Ayse Yasemin Tezer TekceInfectious Diseases and Clinical Microbiology, Ministry of Health, Ankara Bilkent City Hospital, Ankara, Türkiye.
Bedia DincMedical Microbiology, Ministry of Health, Ankara City Hospital, Ankara, Türkiye.
Fisun KircaMedical Microbiology, Ankara Bilkent City Hospital, Ankara, Türkiye.
Hatice Rahmet GunerInfectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Candida aurisCandidemiaAdultAgedAged, 80 and overAntifungal AgentsCandidaCase-Control StudiesCross InfectionDrug Resistance, FungalFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsAntifungal Agentsantifungal resistanceCandida aurisCandidozyma auriscritical carerisk factors

Identifiers

PMID41178291
PMCPMC12641305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.